Publication:
Cytotoxic and Genotoxic Potential of Trigonostemon reidioides Extract on Human Caco-2 Cells

dc.contributor.authorNusuetrong P.
dc.contributor.authorBoonmalert M.
dc.contributor.authorKoobkokkruad T.
dc.contributor.authorChantong B.
dc.contributor.authorNalinratana N.
dc.contributor.authorMeksuriyen D.
dc.date.accessioned2021-04-05T03:22:49Z
dc.date.available2021-04-05T03:22:49Z
dc.date.issued2017
dc.date.issuedBE2560
dc.description.abstractBackground: Trigonostemon reidioides roots have been used as a Thai traditional medicine for the treatment of drug addiction; however, the cytotoxic and genotoxic potential of the herbal extract on human cells have not been clarified. Objective: To evaluate the cytotoxicity and genotoxicity of the ethanolic extract of T. reidioides roots (TR) on human intestinal epithelial Caco-2 cells. Material and Method: Cell viability of TR (0.005 to 0.5 mg/mL)-treated Caco-2 cells was measured by MTT assay after 24 and 48 h exposure. DNA fragmentation was evaluated by Hoechst 33342 staining and comet assay was conducted in the cells treated with TR at the concentrations equal to and higher than the IC50. The protein expressions of ERK1/2 as well as pERK1/ 2 were investigated by immunoblotting. Densitometric analysis of thin layer chromatography (TLC) fingerprint of TR was performed to identify scopoletin content. Results: Exposure of the human Caco-2 cells to TR resulted in decreased cell viability with an IC50 value of approximately 0.2 mg/mL. Treatment of the cells with TR (0.01 mg/mL) for 24 h and 48 h significantly increased (p<0.05) cell proliferation. TR at the concentration of IC50 induced DNA fragmentation, and TR (0.2 to 0.5 mg/mL) significantly increased the percentage of DNA in the tail in a concentration-dependent manner as revealed by comet assay. Immunoblotting revealed that the phosphorylation of ERK1/2 was significantly increased (p<0.05) in the cells treated with TR (0.5 mg/mL) when compared with the control. Scopoletin content in TLC was approximately 271 ng per mg of extract. Conclusion: The present study contributes current evidence that caution must be practiced concerning the dose and duration of T. reidioides root medication. Moreover, further study in animal models concerning its safety application is required to confirm the finding in the cellular level of the present study. © 2017 Medical Association of Thailand. All rights reserved.
dc.format.mimetypeapplication/pdf
dc.identifier.citationJournal of the Medical Association of Thailand. Vol 100, No.10 (2017), p.S61-S68
dc.identifier.issn1252208
dc.identifier.other2-s2.0-85074993734
dc.identifier.urihttps://hdl.handle.net/20.500.14740/4506
dc.rights.holderScopus
dc.subject.otherCytotoxic agent
dc.subject.otherHoe 33342
dc.subject.otherMitogen activated protein kinase 1
dc.subject.otherMitogen activated protein kinase 3
dc.subject.otherPhytochemical
dc.subject.otherPlant extract
dc.subject.otherTrigonostemon reidioide extract
dc.subject.otherUnclassified drug
dc.subject.otherArticle
dc.subject.otherCaco-2 cell line
dc.subject.otherCell proliferation
dc.subject.otherCell viability
dc.subject.otherComet assay
dc.subject.otherCytotoxicity
dc.subject.otherDensitometry
dc.subject.otherDNA fragmentation
dc.subject.otherGenotoxicity
dc.subject.otherHuman
dc.subject.otherHuman cell
dc.subject.otherIC50
dc.subject.otherImmunoblotting
dc.subject.otherMTT assay
dc.subject.otherProtein expression
dc.subject.otherProtein phosphorylation
dc.subject.otherThin layer chromatography
dc.subject.otherWestern blotting
dc.titleCytotoxic and Genotoxic Potential of Trigonostemon reidioides Extract on Human Caco-2 Cells
dc.typeArticle
dspace.entity.typePublication
swu.datasource.scopushttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85074993734&partnerID=40&md5=edeb96b3921ef1a28966c44b9d1eff9b

Files